awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33397131-093F17D2-D115-4C87-BEB2-EEA0F492D724
Q33397131-093F17D2-D115-4C87-BEB2-EEA0F492D724
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-093F17D2-D115-4C87-BEB2-EEA0F492D724
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.
P2860
Q33397131-093F17D2-D115-4C87-BEB2-EEA0F492D724
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33397131-093F17D2-D115-4C87-BEB2-EEA0F492D724
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8e81644fc35b00d657b71d050e065d42f7329072
P2860
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.